Yang F, Wang X, Qi J, Zhang K, Jiang Y, Feng B, et al
Preclinical and clinical studies have demonstrated that bioactive compounds such as polyphenols, alkaloids, terpenoids, saponins, and flavonoids exert beneficial effects on AD-related pathways by reducing oxidative stress, suppressing neuroinflammation, preventing A aggregation, and modulating tau hyperphosphorylation (Md et al., 2021), and interact with estrogen receptor beta (ER), a known regulator of synaptic plasticity and neuroprotection ( 4.6 Overcoming challenges in translating natural compounds into clinical applications Despite promising findings, translating the therapeutic potential of natural compounds into clinical practice presents several key challenges
California ends Medicaid coverage of weight loss drugs despite TrumpRx plan
Dulaglutide showed non-inferiority to liraglutide for HbA 1c reduction at week 26
Patients on immunosuppressive therapy should have a provider review potential interactions before initiating any peptide protocol
doi: 10.1161/CIRCRESAHA.120.316242
